Bostwick J M, Pankratz V S
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA.
Am J Psychiatry. 2000 Dec;157(12):1925-32. doi: 10.1176/appi.ajp.157.12.1925.
In 1970, Guze and Robins published a meta-analysis of suicide in patients with affective illness that inferred a lifetime risk of 15%. Since then, this figure has been generalized to all depressive disorders and cited uncritically in many papers and textbooks. The authors argue for an alternative estimate of suicide risk and question the generalizability of the Guze and Robins estimate.
The authors sorted studies obtained through a literature search that included data pertaining to suicide occurrence in affective illness into one of three groups: outpatients, inpatients, or suicidal inpatients. Suicide risks were calculated meta-analytically for these three groups, as well as for two previously published collections.
There was a hierarchy in suicide risk among patients with affective disorders. The estimate of the lifetime prevalence of suicide in those ever hospitalized for suicidality was 8.6%. For affective disorder patients hospitalized without specification of suicidality, the lifetime risk of suicide was 4.0%. The lifetime suicide prevalence for mixed inpatient/outpatient populations was 2.2%, and for the nonaffectively ill population, it was less than 0.5%.
The percentage of subjects dead due to suicide (case fatality prevalence) is a more appropriate estimate of suicide risk than the percentage of the dead who died by suicide (proportionate mortality prevalence). More important, it is well established that patients with affective disorders suffer a higher risk of suicide relative to the general population. However, no risk factor, including classification of diagnostic subtype, has been reliably shown to predict suicide. This article demonstrates a hierarchy of risk based on the intensity of the treatment setting. Given that patients with a hospitalization history, particularly when suicidal, have a much elevated suicide prevalence over both psychiatric outpatients and nonpatients, the clinical decision to hospitalize in and of itself appears to be a useful indicator of increased suicide risk.
1970年,古泽和罗宾斯发表了一篇关于情感性疾病患者自杀情况的荟萃分析,推断其终生风险为15%。从那时起,这个数字被推广到所有抑郁症,并在许多论文和教科书中被不加批判地引用。作者主张对自杀风险进行另一种估计,并质疑古泽和罗宾斯估计的可推广性。
作者将通过文献检索获得的研究进行分类,这些研究包括与情感性疾病中自杀发生情况相关的数据,分为三组:门诊患者、住院患者或有自杀行为的住院患者。对这三组以及之前发表的两个数据集中的自杀风险进行荟萃分析计算。
情感障碍患者的自杀风险存在层次差异。曾因自杀行为住院的患者中,自杀终生患病率估计为8.6%。未明确提及自杀行为的情感障碍住院患者,自杀终生风险为4.0%。住院和门诊混合人群的自杀终生患病率为2.2%,而非情感性疾病人群则低于0.5%。
因自杀死亡的受试者百分比(病例致死患病率)比自杀死亡者在死亡总数中所占百分比(比例死亡率患病率)更适合作为自杀风险的估计。更重要的是,已明确情感障碍患者相对于一般人群自杀风险更高。然而,没有任何风险因素,包括诊断亚型分类,已被可靠地证明能预测自杀。本文展示了基于治疗环境强度的风险层次。鉴于有住院史的患者,尤其是有自杀行为时,其自杀患病率比精神科门诊患者和非患者都高得多,住院这一临床决策本身似乎是自杀风险增加的一个有用指标。